[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MA40171A - Dérivés d'azamophinan et leur utilisation - Google Patents

Dérivés d'azamophinan et leur utilisation

Info

Publication number
MA40171A
MA40171A MA040171A MA40171A MA40171A MA 40171 A MA40171 A MA 40171A MA 040171 A MA040171 A MA 040171A MA 40171 A MA40171 A MA 40171A MA 40171 A MA40171 A MA 40171A
Authority
MA
Morocco
Prior art keywords
azamophinan
derivatives
solvates
compounds
directed
Prior art date
Application number
MA040171A
Other languages
English (en)
Inventor
Jae Hyun Park
Laykea Tafesse
Original Assignee
Purdue Pharma Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Pharma Lp filed Critical Purdue Pharma Lp
Publication of MA40171A publication Critical patent/MA40171A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention concerne des composés de formule (i), ainsi que des sels et solvates pharmaceutiquement acceptables de ceux-ci. Dans la formule (i), r
MA040171A 2014-06-13 2015-06-12 Dérivés d'azamophinan et leur utilisation MA40171A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462012060P 2014-06-13 2014-06-13

Publications (1)

Publication Number Publication Date
MA40171A true MA40171A (fr) 2017-04-19

Family

ID=54834434

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040171A MA40171A (fr) 2014-06-13 2015-06-12 Dérivés d'azamophinan et leur utilisation

Country Status (6)

Country Link
US (1) US10202382B2 (fr)
EP (1) EP3154972A4 (fr)
JP (1) JP6360915B2 (fr)
CA (1) CA2951697A1 (fr)
MA (1) MA40171A (fr)
WO (1) WO2015192053A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6400592B2 (ja) 2012-11-09 2018-10-03 パーデュー、ファーマ、リミテッド、パートナーシップ ベンゾモルファン類似体およびその使用
EP3087073B1 (fr) 2013-12-26 2018-07-04 Purdue Pharma LP Hydantoïnes de morphinane substitués en position 10
EP3087079B1 (fr) 2013-12-26 2019-04-03 Purdue Pharma LP Morphinanes oxabicyclo[2.2.2]octane modulateurs des récepteurs aux opiacés
WO2015097548A1 (fr) 2013-12-26 2015-07-02 Purdue Pharma L.P. Analogues 7-bêta-alkyle d'orvinols
JP6353543B2 (ja) 2013-12-26 2018-07-04 パーデュー、ファーマ、リミテッド、パートナーシップ 環縮小モルフィナン及びその使用
WO2015099863A1 (fr) 2013-12-27 2015-07-02 Purdue Pharma L.P. Analogues de la morphinane 6-substitués et 7-substitués, et leurs utilisations
US9902726B2 (en) 2013-12-30 2018-02-27 Purdue Pharma L.P. Pyridone-sulfone morphinan analogs as opioid receptor ligands
JP2017521373A (ja) 2014-05-27 2017-08-03 パーデュー、ファーマ、リミテッド、パートナーシップ スピロ環モルフィナン及びその使用
MA40171A (fr) 2014-06-13 2017-04-19 Purdue Pharma Lp Dérivés d'azamophinan et leur utilisation
MA41125A (fr) 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation
WO2018125716A1 (fr) 2017-01-02 2018-07-05 Purdue Pharma L.P. Dérivés de morphinane et leur utilisation
WO2020048828A1 (fr) 2018-09-03 2020-03-12 Bayer Pharma Aktiengesellschaft Composés du 5-hétéroaryl-3,9-diazaspiro[5.5]undécane
AR116020A1 (es) 2018-09-03 2021-03-25 Bayer Ag COMPUESTOS DE 3,9-DIAZAESPIRO[5.5]UNDECANO COMO INHIBIDORES DE GGTasa I Y SU USO PARA EL TRATAMIENTO DE ENFERMEDADES HIPERPROLIFERATIVAS
AU2020360928A1 (en) * 2019-09-30 2022-04-14 Nippon Chemiphar Co., Ltd. Azepan derivative
CN114292889B (zh) * 2022-03-14 2023-11-21 河南省医药科学研究院 一种紫穗槐花多糖的制备方法及其应用
EP4265663A1 (fr) 2022-04-21 2023-10-25 Covestro Deutschland AG Compositions de revêtement à deux composants à base de polyaspartate destinées à la fabrication de revêtements présentant de bonnes propriétés d'auto-cicatrisation et en même temps une faible adhérence

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3285922A (en) * 1962-01-26 1966-11-15 Research Corp N-cyclopropylmethyl-and -cyclobutyl-methyl-morphinans
US3300500A (en) 1962-04-09 1967-01-24 Alkylmorphinan derivatives and production thereof
CA1093070A (fr) 1978-02-10 1981-01-06 Michael P. Kotick Traduction non-disponible
HU196376B (en) * 1985-05-23 1988-11-28 Sandoz Ag Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds
IL132522A0 (en) 1997-04-22 2001-03-19 Cocensys Inc Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and pharmaceutical compositions containing the same
WO1999026614A1 (fr) 1997-11-21 1999-06-03 Euro-Celtique S.A. 2-aminoacetamides substitues et leur utilisation
US6281211B1 (en) 1999-02-04 2001-08-28 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
CN1353605A (zh) 1999-03-26 2002-06-12 欧洲凯尔特股份有限公司 芳基取代的吡唑、咪唑、噁唑、噻唑和吡咯及其应用
CA2370030C (fr) 1999-04-09 2007-08-14 Euro-Celtique S.A. Composition de blocage du canal sodique et leur utilisation
AR029489A1 (es) 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
US7078426B2 (en) 2000-03-24 2006-07-18 Euro-Celtique S.A. Aryl substituted pyrazoles, triazoles, and tetrazoles, and the use thereof
EP1268427A1 (fr) 2000-03-31 2003-01-02 Cocensys, Inc. Aminopyridines et leur utilisation en tant qu'anticonvulsants et inhibiteurs du canal sodium
EP1368356A2 (fr) 2001-03-02 2003-12-10 Euro-Celtique S.A. N-but-3-enyl norbuprenorphine et utilisations
CA2453633A1 (fr) 2001-07-16 2003-01-30 Euro-Celtique S.A. Thiazolidinones a substitution aryle et utilisations
US6740641B2 (en) 2001-07-27 2004-05-25 Euro-Celtique, S.A. Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain
AR036873A1 (es) 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
AR037233A1 (es) 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
CN1646500A (zh) 2002-03-13 2005-07-27 欧洲凯尔特股份有限公司 芳基取代的嘧啶及其用途
CN1671672A (zh) 2002-07-31 2005-09-21 欧洲凯尔特股份有限公司 芳基取代的苯并咪唑类及其作为钠通道阻滞剂的用途
WO2004010950A2 (fr) 2002-07-31 2004-02-05 Euro-Celtique S.A. Composes hydantoine aryle substitues et utilisation de ces composes comme bloqueurs de canal sodium
US20040152696A1 (en) 2002-08-01 2004-08-05 Euro-Celtique S.A. 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers
PT1543010E (pt) 2002-09-25 2007-07-26 Euro Celtique Sa Hidromorfonas n-substituídas e a sua utilização
WO2004039317A2 (fr) 2002-10-25 2004-05-13 Euro-Celtique S.A. Analogues et promedicaments de buprenorphine
US7202259B2 (en) 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US6958398B1 (en) 2002-12-30 2005-10-25 Euro-Celtique S.A. Methods for making thebaine or its acid salts
WO2005014849A2 (fr) 2003-07-03 2005-02-17 Euro-Celtique, S.A. Genes associes a des reponses a des douleurs neuropathiques
TWI381838B (zh) 2006-11-01 2013-01-11 Purdue Pharma Lp 苯基丙醯胺化合物及其應用
CA2707174C (fr) 2007-11-30 2013-12-31 Purdue Pharma L.P. Composes a base de benzomorphane
RU2520222C2 (ru) 2008-07-30 2014-06-20 Пэдью Фарма Л.П. Аналоги бупренорфина
PT2506712T (pt) * 2009-12-04 2019-05-31 Alkermes Pharma Ireland Ltd Derivados de morfinano para o tratamento da overdose por fármaco
JP2013530180A (ja) 2010-06-16 2013-07-25 パーデュー、ファーマ、リミテッド、パートナーシップ アリール置換インドールおよびその使用
JP2013531687A (ja) 2010-07-16 2013-08-08 パーデュー、ファーマ、リミテッド、パートナーシップ ナトリウムチャネル遮断剤としてのピリジン化合物
EP3590925B1 (fr) 2010-09-17 2022-03-30 Purdue Pharma L.P. Composés de pyridine et ses utilisations
HUE027195T2 (en) 2010-09-21 2016-10-28 Purdue Pharma Lp Buprenorphine analogues as opioid receptor agonists and / or antagonists
ES2540562T3 (es) 2010-10-05 2015-07-10 Purdue Pharma L.P. Compuestos de quinazolina como bloqueadores de canales de sodio
WO2012085650A1 (fr) 2010-12-22 2012-06-28 Purdue Pharma L.P. Pyridines substituées en tant que bloqueurs de canaux sodiques
CA2840643C (fr) 2011-06-29 2017-11-21 Alkermes, Inc. Composes opioides agissant sur le systeme nerveux peripherique
US9163008B2 (en) 2011-09-02 2015-10-20 Purdue Pharma, L.P. Pyrimidines as sodium channel blockers
AU2012321111A1 (en) 2011-10-31 2013-05-16 Purdue Pharma L.P. Quaternized amines as sodium channel blockers
US9181185B2 (en) 2011-10-31 2015-11-10 Purdue Pharma L.P. Heteroaryl compounds as sodium channel blockers
WO2013072758A1 (fr) 2011-11-15 2013-05-23 Purdue Pharma L.P. Pyrimidine diol amides comme bloqueurs des canaux sodiques
AU2012324012A1 (en) 2011-12-08 2013-06-27 Purdue Pharma L.P. Quaternized buprenorphine analogs
US9206127B2 (en) 2012-03-16 2015-12-08 Purdue Pharm, L.P. Substituted pyridines as sodium channel blockers
AR091027A1 (es) 2012-05-11 2014-12-30 Purdue Pharma Lp Analogos de benzomorfano y el usos de estos
US9315514B2 (en) 2012-08-27 2016-04-19 Rhodes Technologies 1,3-dioxanomorphides and 1,3-dioxanocodides
JP6400592B2 (ja) 2012-11-09 2018-10-03 パーデュー、ファーマ、リミテッド、パートナーシップ ベンゾモルファン類似体およびその使用
EP2931729B1 (fr) 2012-12-07 2019-02-06 Purdue Pharma LP Analogues de buprénorphine en tant que modulateurs d'un récepteur des opioïdes
TWI513697B (zh) 2012-12-14 2015-12-21 Purdue Pharma Lp 吡啶酮並嗎啡喃類似物及其對類鴉片受體之生物活性
JP6163210B2 (ja) * 2012-12-14 2017-07-12 パーデュー、ファーマ、リミテッド、パートナーシップ 窒素含有モルフィナン誘導体およびその使用
EP2931726B1 (fr) 2012-12-14 2017-01-25 Purdue Pharma LP Morphinanes spirocycliques et leur utilisation
WO2014096941A1 (fr) 2012-12-20 2014-06-26 Purdue Pharma L.P. Sulfonamides cycliques en tant que bloquants des canaux sodiques
CA2896202A1 (fr) 2012-12-28 2014-07-03 Purdue Pharma L.P. Morphinanes substitues et utilisation de ceux-ci
WO2014102587A1 (fr) 2012-12-28 2014-07-03 Purdue Pharma L.P. Analogues de 7,8-cyclicmorphinane
US9056836B2 (en) 2013-01-31 2015-06-16 Purdue Pharma L.P. Benzomorphan analogs and the use thereof
ES2680246T3 (es) 2013-03-04 2018-09-05 Purdue Pharma Lp Pirimidincarboxamidas como bloqueantes de canal de sodio
US9120786B2 (en) 2013-03-04 2015-09-01 Purdue Pharma, L.P. Triazine carboxamides as sodium channel blockers
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
AU2014235063B2 (en) 2013-03-15 2017-05-04 Purdue Pharma L.P. Carboxamide derivatives and use thereof
JP6161801B2 (ja) 2013-05-24 2017-07-12 ローズ テクノロジーズ オピオイドケタール化合物及びその使用
US9359330B2 (en) 2013-08-26 2016-06-07 Purdue Pharma L.P. Substituted piperidines as sodium channel blockers
US9828348B2 (en) 2013-11-08 2017-11-28 Purdue Pharma L.P. Benzimidazole derivatives and use thereof
US9340504B2 (en) 2013-11-21 2016-05-17 Purdue Pharma L.P. Pyridine and piperidine derivatives as novel sodium channel blockers
US9695144B2 (en) 2013-12-23 2017-07-04 Purdue Pharma L.P. Dibenzazepine derivatives and use thereof
JP6353543B2 (ja) 2013-12-26 2018-07-04 パーデュー、ファーマ、リミテッド、パートナーシップ 環縮小モルフィナン及びその使用
EP3087079B1 (fr) 2013-12-26 2019-04-03 Purdue Pharma LP Morphinanes oxabicyclo[2.2.2]octane modulateurs des récepteurs aux opiacés
WO2015097546A1 (fr) 2013-12-26 2015-07-02 Purdue Pharma L.P. Composés à base de propellane et utilisation de ces derniers en qualité de modulateurs de récepteurs d'opioïdes
WO2015100092A2 (fr) 2013-12-26 2015-07-02 Purdue Pharma L.P. Analogues 7-bêta d'orvinols
EP3087073B1 (fr) 2013-12-26 2018-07-04 Purdue Pharma LP Hydantoïnes de morphinane substitués en position 10
WO2015097548A1 (fr) 2013-12-26 2015-07-02 Purdue Pharma L.P. Analogues 7-bêta-alkyle d'orvinols
WO2015099863A1 (fr) 2013-12-27 2015-07-02 Purdue Pharma L.P. Analogues de la morphinane 6-substitués et 7-substitués, et leurs utilisations
US9902726B2 (en) 2013-12-30 2018-02-27 Purdue Pharma L.P. Pyridone-sulfone morphinan analogs as opioid receptor ligands
CN106061944A (zh) 2014-01-24 2016-10-26 普渡制药公司 吡啶类和嘧啶类物质及其用途
CA2939501C (fr) 2014-02-12 2020-07-07 Purdue Pharma L.P. Derives d'isoquinoline et leur utilisation
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
US9975854B2 (en) 2014-05-06 2018-05-22 Purdue Pharma L.P. Benzomorphan analogs and use thereof
JP2017521373A (ja) 2014-05-27 2017-08-03 パーデュー、ファーマ、リミテッド、パートナーシップ スピロ環モルフィナン及びその使用
US10131666B2 (en) 2014-06-13 2018-11-20 Purdue Pharma L.P. Heterocyclic morphinan derivatives and use thereof
MA40171A (fr) 2014-06-13 2017-04-19 Purdue Pharma Lp Dérivés d'azamophinan et leur utilisation
US10130615B2 (en) 2014-09-17 2018-11-20 Purdue Pharma L.P. Benzomorphan analogs and the use thereof

Also Published As

Publication number Publication date
EP3154972A4 (fr) 2017-11-22
WO2015192053A1 (fr) 2015-12-17
EP3154972A1 (fr) 2017-04-19
CA2951697A1 (fr) 2015-12-17
JP2017517559A (ja) 2017-06-29
US10202382B2 (en) 2019-02-12
JP6360915B2 (ja) 2018-07-18
US20170107220A1 (en) 2017-04-20

Similar Documents

Publication Publication Date Title
MA40171A (fr) Dérivés d'azamophinan et leur utilisation
MA40170A (fr) Dérivés hétérocycliques de morphinan et leur utilisation
PH12019501321B1 (en) Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders
MA40058A (fr) Composés inhibiteurs de kinases se liant à tank
MD20160106A2 (ro) Compuşi aril sau heteroaril biciclici condensaţi şi utilizarea acestora ca inhibitori IRAK4
TW201613872A (en) IRAK4 inhibiting agents
MX2017004200A (es) Compuestos de heteroarilo como inhibidores de tirosina-cinasa de bruton (btk) y usos de estos.
JO3317B1 (ar) مركبات تترا هيدروبيرولو ثيازين
MX2017006266A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1(irak) y sus usos.
AU2014267235A8 (en) Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
MA39749A (fr) Dérivés de pipéridine-dione
MX2017003930A (es) Derivados de aminotriazina utiles como compuestos inhibidores de la cinasa de union a tank.
MA39866A (fr) Amides 2-amino-6-méthyl-4,4a,5,6-tétrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yle
MX2018004664A (es) Antagonistas de ep4.
MX2017001565A (es) Compuestos de imidazopiridazina.
MA40250A (fr) Dérivés de quinolizinone utilisés comme inhibiteurs de pi3k
SA517381678B1 (ar) مركبات داي هيدرو بيريميدين-2-أون واستخدامها الطبي
MX2015013224A (es) Inhibidores macrociclicos y biciclicos del virus de la hepatitis c.
JOP20190163B1 (ar) منشط nrf2
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
AU2015292632B2 (en) Aldosterone synthase inhibitors
EA201491227A1 (ru) Новые производные морфолинила, подходящие для применения в качестве ингибиторов mogat-2
IN2013MU03862A (fr)
EA201791099A1 (ru) Хинолин карбоксамиды для применения в лечении лейкоза
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases